CREDIT SUISSE AG/ - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 116 filers reported holding AXSOME THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.5%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,004,207
-8.0%
57,293
-5.4%
0.00%0.0%
Q2 2023$4,352,776
+75.4%
60,573
+50.6%
0.00%
+33.3%
Q1 2023$2,480,954
-28.7%
40,223
-10.9%
0.00%
-25.0%
Q4 2022$3,481,803
+26.7%
45,142
-26.7%
0.00%
+33.3%
Q3 2022$2,749,000
+98.3%
61,616
+70.2%
0.00%
+200.0%
Q2 2022$1,386,000
-27.5%
36,203
-21.6%
0.00%
-50.0%
Q1 2022$1,911,000
-58.6%
46,159
-62.2%
0.00%0.0%
Q4 2021$4,619,000
+42.2%
122,243
+24.0%
0.00%0.0%
Q3 2021$3,249,000
+37.1%
98,582
+180.6%
0.00%
+100.0%
Q2 2021$2,369,000
+7.7%
35,127
-9.5%
0.00%0.0%
Q1 2021$2,199,000
-25.8%
38,833
+6.8%
0.00%0.0%
Q4 2020$2,963,000
+85.2%
36,370
+62.0%
0.00%0.0%
Q3 2020$1,600,000
-28.4%
22,452
-17.3%
0.00%
-50.0%
Q2 2020$2,234,000
+140.7%
27,148
+72.0%
0.00%
+100.0%
Q1 2020$928,000
-77.9%
15,780
-61.1%
0.00%
-66.7%
Q4 2019$4,193,000
+1030.2%
40,567
+121.4%
0.00%
Q3 2019$371,000
-35.3%
18,322
-17.7%
0.00%
-100.0%
Q2 2019$573,000
+516.1%
22,265
+31.3%
0.00%
Q2 2017$93,00016,9530.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 758,794$53,032,11365.14%
Fairmount Funds Management LLC 2,341,238$163,629,12419.69%
Ally Bridge Group (NY) LLC 110,600$7,729,8349.07%
RTW INVESTMENTS, LP 4,489,596$313,777,8646.62%
SVB FINANCIAL GROUP 33,849$2,365,7074.45%
BVF INC/IL 2,131,100$148,942,5794.02%
Altium Capital Management LP 92,000$6,429,8803.35%
Tri Locum Partners LP 142,510$9,960,0243.18%
TANG CAPITAL MANAGEMENT LLC 320,000$22,364,8003.16%
Deep Track Capital, LP 1,140,745$79,726,6683.08%
View complete list of AXSOME THERAPEUTICS INC shareholders